net dbt
overshadow medic ep beat
dental soft consumables/equip
reduc estim organ growth outlook dental
consum softer data point dental manufactur link
even na dental consum came estim vs difficult
comparison na dental equip intern dental equip saw declin
surpris given expect ids-rel boost well recent new product
launch dentspli sirona primescan ep came
expect guidanc maintain think soft seen dental broadli
quarter like overshadow everyth els includ strong medic organ
growth like pressur share magnitud move driven
understand reason under-perform whether factor
like revers near-term reiter neutral rate medic organ growth
continu solid perform help lead ep beat guidanc maintain
weak na dental consum equip growth
total revenu street estim
estim dental revenu street estim
estim na dental consum grow
organ na dental equip declin vs estim
respect medic revenu street estim
estim adjust ep
street estim estim aid better gross margin vs
maintain ep guidanc expect vs street
estim estim outlook adjust ep exclud
restructur expens credit incom tax expens relat
topic call
import factor quarter drove weaker perform
dental north america slower consum growth equip declin
whether compani believ growth inflect also await commentari
around health underli equip market given surprisingli weak growth
particularli around cad/cam dental implant expect demand post-id
furthermor expect get addit detail compani immedi
intermedi capit deploy plan follow receipt cash dividend
anim spin includ balanc strateg expans vs intern
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
million except per share data
revenu
equiti incom affili
compani file bofa merril lynch global research estim
price object base ev/ebitda close
compani histor trade rang account less visibl growth/margin
opportun off-set demographically-posit end market increment
contribut increas technolog revenu
upsid risk po stronger expect dental consumable/equip sale
either new relationship sirona share win faster uptak
one jv cost ration downsid risk uncertainti creat ftc
complaint alleg price conspiraci henri schein/patterson
companies/benco dental suppli wors expect share gain sirona-rel
revenu new competit amazon creat signific growth margin
pressur segment
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
